MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
electroCore General and Administrative Expenses 2011-2026 | ECOR
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses electroCore
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27.2 M | 24.3 M | 21.6 M | 21.8 K | 35.4 M | 42.5 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.5 M | 21.8 K | 25.2 M |
Quarterly General and Administrative Expenses electroCore
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.69 M | 9.44 M | 8.89 M | - | 7.62 M | 7.26 M | 8 M | - | 6.72 M | 6.8 M | 6.71 M | - | 5.66 M | 6.28 M | 6.19 M | - | 4.65 M | 5.27 M | 5.72 M | - | 4.59 M | 5.27 M | 6.56 M | - | 8.14 M | 9.39 M | 11 M | - | 11.3 M | 12 M | 6.82 M | - | 4.26 M | 4.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12 M | 4.26 M | 7.27 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
2.97 B | $ 19.11 | -0.98 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 194.07 | -0.8 % | $ 55.8 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
8.79 M | $ 8.64 | -18.34 % | $ 174 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
22.8 M | $ 0.67 | 1.66 % | $ 28.4 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
251 M | $ 78.81 | -0.64 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
20.4 M | $ 5.81 | 2.11 % | $ 265 M | USA |
 |
AtriCure
ATRC
|
291 M | $ 39.56 | -1.54 % | $ 1.86 B | USA |
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M | USA |
 |
ICU Medical
ICUI
|
639 M | $ 142.67 | -1.36 % | $ 3.48 B | USA |
 |
iRhythm Technologies
IRTC
|
419 M | $ 177.44 | -0.63 % | $ 5.54 B | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 12.84 | -1.23 % | $ 525 M | USA |
 |
Isoray
ISR
|
26.6 M | - | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 81.96 | -0.62 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
224 M | $ 112.91 | -1.16 % | $ 5.47 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 81.1 | -2.3 % | $ 1.82 B | USA |
 |
Haemonetics Corporation
HAE
|
437 M | $ 80.15 | -1.02 % | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
46.1 M | $ 8.97 | 0.67 % | $ 185 M | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 130.06 | -0.77 % | $ 6.93 B | USA |
 |
Merit Medical Systems
MMSI
|
400 M | $ 88.14 | -0.47 % | $ 5.13 B | USA |
 |
OraSure Technologies
OSUR
|
46.2 M | $ 2.42 | -2.02 % | $ 180 M | USA |
 |
Intuitive Surgical
ISRG
|
2.14 B | $ 566.36 | -1.09 % | $ 201 B | USA |
 |
Microbot Medical
MBOT
|
4.13 M | $ 2.0 | -2.44 % | $ 20.4 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.3 M | $ 0.27 | -0.22 % | $ 21.5 M | USA |
 |
Nephros
NEPH
|
8.91 M | $ 4.88 | 3.39 % | $ 50.7 M | USA |
 |
Stereotaxis
STXS
|
14 M | $ 2.3 | -0.22 % | $ 186 M | USA |
 |
NeuroMetrix
NURO
|
6.33 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 21.71 | -0.91 % | $ 3.74 B | USA |
 |
STERIS plc
STE
|
1.33 B | $ 253.52 | -0.76 % | $ 25 B | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 38.48 | -0.3 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
7.42 M | - | - | $ 32.4 M | USA |
 |
Pulse Biosciences
PLSE
|
15.8 M | $ 13.73 | 0.22 % | $ 660 M | USA |
 |
Utah Medical Products
UTMD
|
11 M | $ 55.96 | -0.57 % | $ 203 M | USA |
 |
ResMed
RMD
|
739 M | $ 240.87 | -0.91 % | $ 35.2 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.6 B | $ 11.43 | 0.35 % | $ 2.32 B | USA |
 |
Repligen Corporation
RGEN
|
219 M | $ 163.86 | -1.64 % | $ 9.13 M | USA |
 |
BioLife Solutions
BLFS
|
40.5 M | $ 24.18 | -1.95 % | $ 1.11 B | USA |
 |
Retractable Technologies
RVP
|
13.6 M | $ 0.77 | -0.63 % | $ 23.1 M | USA |
 |
STAAR Surgical Company
STAA
|
89.9 M | $ 23.09 | -0.52 % | $ 1.13 B | USA |
 |
Teleflex Incorporated
TFX
|
995 M | $ 122.04 | 0.35 % | $ 5.72 B | USA |
 |
West Pharmaceutical Services
WST
|
338 M | $ 275.14 | -0.62 % | $ 20.1 B | USA |